KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of URGN
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

UroGen Pharma Ltd stock price up 2.39% on Friday
(Updated on Apr 26, 2024)

Sell candidate since Apr 23, 2024 Loss -2.62% PDF

The UroGen Pharma Ltd stock price gained 2.39% on the last trading day (Friday, 26th Apr 2024), rising from $13.82 to $14.15. During the last trading day the stock fluctuated 4.60% from a day low at $13.69 to a day high of $14.32. The price has fallen in 5 of the last 10 days and is down by -6.29% for this period. Volume fell on the last day by -42 thousand shares and in total, 134 thousand shares were bought and sold for approximately $1.90 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -23.16% during the next 3 months and, with a 90% probability hold a price between $9.25 and $12.04 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

URGN Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The UroGen Pharma Ltd stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $14.15 and $14.74. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, April 15, 2024, and so far it has fallen -6.29%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for UroGen Pharma Ltd stock

UroGen Pharma Ltd finds support from accumulated volume at $13.73 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.630 between high and low, or 4.60%. For the last week, the stock has had daily average volatility of 5.20%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (URGN) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect UroGen Pharma Ltd to open at $14.05, and during the day (based on 14 day Average True Range), to move between $13.22 and $15.08, which gives a possible trading interval of +/-$0.93 (+/-6.55%) up or down from last closing price. If UroGen Pharma Ltd takes out the full calculated possible swing range there will be an estimated 13.10% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $13.73 (2.97%) than the resistance at $15.10 (6.71%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is UroGen Pharma Ltd stock A Buy?

UroGen Pharma Ltd holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.759 Sell Candidate Unchanged

Predicted Opening Price for UroGen Pharma Ltd of Monday, April 29, 2024

Fair opening price April 29, 2024 Current price
$14.05 ( 0.683%) $14.15

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for URGN

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 14.68 3.77 %
R2 14.44 2.07 %
R1 14.29 1.02 %
Current price: 14.15
Support S1 13.81 -2.38 %
S2 13.66 -3.43 %
S3 13.42 -5.14 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 16.66 17.74 %
R2 15.76 11.38 %
R1 15.10 6.71 %
Current price 14.15
Support S1 13.73 -2.97%
S2 13.25 -6.36%
S3 12.95 -8.48%

FAQ

What is the symbol for UroGen Pharma Ltd Stock and on which exchange is it traded?
The symbol for UroGen Pharma Ltd is URGN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell UroGen Pharma Ltd Stock?
UroGen Pharma Ltd holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy UroGen Pharma Ltd Stock?
UroGen Pharma Ltd Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy UroGen Pharma Ltd Stock.

What's the current price of UroGen Pharma Ltd Stock?
As of the end of day on the Apr 26, 2024, the price of an UroGen Pharma Ltd (URGN) share was $14.15.

What is the 52-week high and low for UroGen Pharma Ltd Stock?
The 52-week high for UroGen Pharma Ltd Stock is $24.13 and the 52-week low is $8.69.

What is the market capitalization of UroGen Pharma Ltd Stock?
As of the Apr 26, 2024, the market capitalization of UroGen Pharma Ltd is 482.828M.

When is the next earnings date for UroGen Pharma Ltd?
The upcoming earnings date for UroGen Pharma Ltd is May 09, 2024.
Click to get the best stock tips daily for free!

About UroGen Pharma Ltd

UroGen Pharma Ltd UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead product candidate is UGN-102, which is in Phase III clinical trials for the treatment of several forms... URGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT